Vinay Prasad Resigns from FDA Amidst Conservative Criticism and Gene Therapy Controversy

FDA Regulator's Departure

• 💡 Vinay Prasad, a critic of the COVID-19 pandemic response and vaccines, resigned from his role leading the FDA's Center for Biologics Evaluation and Research.
• 🎯 His appointment was made by Secretary Robert F. Kennedy Jr., but Prasad faced criticism from the right over drug approvals and past support for Democratic politicians.

Gene Therapy Drug Controversy

• ⚠️ The immediate trigger for Prasad's resignation appears to be the FDA's request for Serespta to pause distribution of its gene therapy drug, Elvidys, after three patients died.
• 📌 Serespta refused to pause distribution, leading to criticism from figures like Senator Rick Santorum and an op-ed describing Prasad as a "one-man death panel."
• ✅ The FDA later lifted the hold on the drug for patients who could still walk, but the controversy had already led to Prasad's departure.

Political and Media Reactions

• 🗣️ Laura Loomer publicly slammed Prasad as a "leftist saboteur" undermining the "Make America Healthy Again" agenda.
• 🔍 Reporter Matthew Zaitland described the situation as a demonstration of how Washington works, where a "COVID contrarian doctor" can be quickly removed after criticism from conservative figures.
• 🤔 The hosts speculate that the drug company may have manufactured outrage by digging up old tweets to pressure for Prasad's ouster, rather than genuine policy disagreements.

Analysis of Prasad's Role and FDA Policies

• 🧠 Prasad is described as a well-informed commentator on health issues, not "crank crazy," and was seen as a good addition to the FDA.
• ⚖️ The discussion highlights the difference in regulation between food and drugs, with drugs requiring a higher safety standard due to potential government recommendation and subsidy.
• 🚀 The hosts express a preference for making drugs more available, aligning with a "right to try" approach, but acknowledge the need for safety standards, especially when public funds are involved.
• 📢 Criticism is leveled against the selective outrage and influence of figures like Laura Loomer, who have allegedly driven people out of the administration.